MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Almost one third (32 per cent) of Canadian respondents to a survey that say they are active on social media post about their plans before or while traveling, a figure that rises to 51 per cent among those aged 18 to 34. Posting that beach vacation selfie…

Société Européenne au capital de € 361 015 032 - 582 110 987 R.C.S Paris30 avenue Montaigne - 75008 Paris INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) -- In a landmark achievement that solidifies Area 52's position as the Delta 8 market leader, The Oregon Observer's extensive 2025 cannabis edibles review has awarded the top Delta 8 gummy rankings to Area 52's innovative product line. This unprecedented sweep demonstrates the brand's unwavering commitment to…

SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has successfully completed two human clinical trials evaluating the effects of oral L-ergothioneine (Dr.Ergo®) on skin health. Abinopharm, Inc. is the…

SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD)…